ImmunoCellular Therapeutics, Ltd. (IMUC) |
---|
$1.83 52 Week Low | $2.35 2017-04-28 14:34:16 MDT | $12.4 52 Week High |
Healthcare Sector | Biotechnology Industry |
NYSE Stock Exchange | United States Country |
Market Cap: | $8,600,000 | Micro Cap (Less than $200M) |
Analyst Recommendation: | 3 | Analysts say: Neutral. (1=Strong Buy, 5=Strong Sell) |
Beta: | 0.49 | Low Volatility Stock (beta under 1). Stock will go up less when the market goes up, and go down less when the market goes down. Beta of 1 means stock would match the S&P 500 Index. |
ForwardPE: Unknown | 5 Yr Est Growth: Unknown | Yield: 0.00% |
PEG-Y Ratio: N/A | Unknown PEG-Y ratio |
% Above 50 DayMA: -12.64% | % Above 200 DayMA: -16.67% |
IMUC Performance 52 Weeks: -76.94% | S&P 500 Performance 52 Weeks: 13.50% |
Downtrend is still intact: IMUC is below both 50 and 200 day Moving Averages. Currently beyond technical death cross because 50 Day MA is below 200 Day MA. Stock is closer to 52 Week Low than 52 Week High. | IMUC underperforming S&P 500 by -90.44% the last 52 Weeks. |
Price To Book: 1.42 | Great Value. Low Price to Book means better value. |
EV to EBITDA: 0.12 | Great Value! A low EV to EBITDA ratio is great. Ideally, under 10. Under 17 is okay. |
Field | Value | Average | Comments |
---|---|---|---|
% Held By Insiders | N/A | 17.28% | Unknown. |
% Held By Institutions | N/A | 62.07% | Unknown. |
Short % Of Float | 10.69% | 07.02% | Shorted by greater than average percent. Investors and traders do not believe in stock. But watch out for short squeezes pushing stock upwards. |
Debt to Equity | N/A | 1.08 | Unknown. |
Profit Margin % | N/A | -00.18% | Unknown. |
Operating Margin % | N/A | -05.28% | Unknown. |
Return on Equity % | -158.59% | -08.79% | Return on Equity less than average percent. Stock can do better than this? |
Return on Assets % | -62.30% | -01.29% | Return on Assets less than average percent. Stock can do better than this? |
Revenue Per Employee | $N/A | $883,096.70 | Unknown. |
Price to Cash | 0.71 | 5.52 | Lower than average Price to Cash. Meaning that the company has a higher percentage of cash as a percent of price. Cash can be good to cushion company during hard times, and as a potential source for buyouts or investments. However, some activists want the cash to be used by a company to buy its own stock, or to increase their dividend, or to invest the money. |
CPEGY Ratio | N/A | 2.26 | Unknown. |
PROS:
| CONS:
|